VASCADE MVP? Venous Vascular Closure System  - Femoral artery compression plug, collagen Australia - English - Department of Health (Therapeutic Goods Administration)

vascade mvp? venous vascular closure system - femoral artery compression plug, collagen

haemonetics australia pty ltd - 60710 - femoral artery compression plug, collagen - the vascade family of devices are gamma sterilized, single-use, disposable devices delivering an extravascular resorbable collagen plug to block blood flow from the femoral vessel access site at the end of a catheterization procedure. the vascade mvp vvcs is used in conjunction with a 6-12f inner diameter introducer sheaths for femoral venous access closure. vascade family devices are intended for the percutaneous closure of femoral vessel access sites in patients who have undergone catheter-based procedures.

VASCADE? Vascular Closure System - Femoral artery compression plug, collagen Australia - English - Department of Health (Therapeutic Goods Administration)

vascade? vascular closure system - femoral artery compression plug, collagen

haemonetics australia pty ltd - 60710 - femoral artery compression plug, collagen - the vascade family of devices are gamma sterilized, single-use, disposable devices delivering an extravascular resorbable collagen plug to block blood flow from the femoral vessel access site at the end of a catheterization procedure. the vascade devices are used in conjunction with a 5-7f inner diameter introducer sheaths for femoral arterial or venous access closure. vascade family devices are intended for the percutaneous closure of femoral vessel access sites in patients who have undergone catheter-based procedures.

HAEMONETICS ANTICOAGULANT SODIUM CITRATE- trisodium citrate dihydrate solution United States - English - NLM (National Library of Medicine)

haemonetics anticoagulant sodium citrate- trisodium citrate dihydrate solution

haemonetics corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 40 mg in 1 ml

HAEMONETICS ADDITIVE SOLUTION FORMULA 3 (AS-3)- citric acid monohydrate, sodium phosphate, monobasic, monohydrate, sodium chlori United States - English - NLM (National Library of Medicine)

haemonetics additive solution formula 3 (as-3)- citric acid monohydrate, sodium phosphate, monobasic, monohydrate, sodium chlori

haemonetics corporation - citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 4.2 mg in 1 ml